Rheumatoid Arthritis

Top Story

FDA approves Avsola, fourth Remicade biosimilar

December 6, 2019
Feature

Podcasts driving a revolution in rheumatology medical education

December 6, 2019
When journalist Ben Hammersley coined the word “podcast” in 2004, he was attempting to put a name to the phenomenon resulting from the timely convergence of…
In the Journals

RA increases risk for CV disease, sleep apnea, venous thromboembolism

December 5, 2019
Patients with inflammatory bowel disease, type 1 diabetes and venous thromboembolism have an increased risk for rheumatoid arthritis, which in turn increases the risk…
In the Journals

Risk for immune-mediated inflammatory diseases 5-times higher in psoriasis

December 3, 2019
Among a large cohort of patients with psoriasis, researchers found around 20% had an immune-mediated inflammatory disease develop before psoriasis onset and 14% had one…
More Headlines »
CME

Rheumatic Complications of Cancer Immunotherapy: A New and Emerging Field in Rheumatology

This activity is supported by an educational grant from Bristol-Myers Squibb.

The introduction of immune checkpoint inhibitors has had a great impact on the field of oncology. However, these new…
More »
Video
Meeting News

Baricitinib maintains safety profile in RA, shows promise for lupus

October 31, 2018
More »
CME

Virtual RA Forum®: Applying Recent Advances to Improve Quality Care

This activity is supported by an educational grant from Pfizer, Inc.

Rheumatoid arthritis (RA) is a progressive and painful systemic inflammatory disease that preferentially attacks the…
More »